TechCrunch first reported on Accel’s talks to back Truemeds last year. Existing investors WestBridge Capital and InfoEdge Ventures, also participated. The fresh round has boosted Truemeds’ valuation …
Why investors just bet $85M on this Indian company’s generic drug strategy
view original post